Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Insights into Therapy Resistance in Osteosarcoma
Zachary D. Prudowsky, Jason T. Yustein
Cancers (2020) Vol. 13, Iss. 1, pp. 83-83
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases
Yao Yao, Xiaoyu Cai, Fujia Ren, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 150
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
Claudia Maria Hattinger, Maria Pia Patrizio, Leonardo Fantoni, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2878-2878
Open Access | Times Cited: 83
An overview of resistance to chemotherapy in osteosarcoma and future perspectives
Dorian Yarih García-Ortega, Sara Aileen Cabrera-Nieto, Haydee Sarai Caro-Sánchez, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 2, pp. 762-93
Open Access | Times Cited: 41
Squishy matters – Corneal mechanobiology in health and disease
Sara M. Thomasy, Brian C. Leonard, Mark A. Greiner, et al.
Progress in Retinal and Eye Research (2024) Vol. 99, pp. 101234-101234
Open Access | Times Cited: 13
3D-Printed Magnesium Peroxide-Incorporated Scaffolds with Sustained Oxygen Release and Enhanced Photothermal Performance for Osteosarcoma Multimodal Treatments
Xu Haixia, Ziyue Peng, Lin Jiezhao, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 8, pp. 9626-9639
Closed Access | Times Cited: 8
Forequarter amputation: a viable approach for salvaging lives in chemoresistant upper limb bone tumours
Rini B. Ratan, Prateek Behera, Vaishnavi Patange, et al.
BMJ Case Reports (2025) Vol. 18, Iss. 1, pp. e262150-e262150
Closed Access | Times Cited: 1
A novel molecular classification method for osteosarcoma based on tumor cell differentiation trajectories
Hao Zhang, Ting Wang, Haiyi Gong, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Targeting ferroptosis in osteosarcoma
Jiazheng Zhao, Yi Zhao, Xiaowei Ma, et al.
Journal of bone oncology (2021) Vol. 30, pp. 100380-100380
Open Access | Times Cited: 34
Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells
Qingxin Fan, Jing Zuo, Hailong Tian, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 27
MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity
Negin Soghli, Gordon A. Ferns, Fatemeh Sadeghsoltani, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115094-115094
Closed Access | Times Cited: 27
USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ
Putao Yuan, Zhenhua Feng, Hai Huang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3122-3136
Open Access | Times Cited: 25
Bifunctional scaffolds for tumor therapy and bone regeneration: Synergistic effect and interplay between therapeutic agents and scaffold materials
Jiongpeng Yuan, Zhaoyi Ye, Yaoxun Zeng, et al.
Materials Today Bio (2022) Vol. 15, pp. 100318-100318
Open Access | Times Cited: 24
Functions and therapeutic potentials of exosomes in osteosarcoma
Jiaji Yue, Zhe‐Sheng Chen, Xiang‐Xi Xu, et al.
Acta Materia Medica (2022) Vol. 1, Iss. 4
Open Access | Times Cited: 24
Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma
Xiaozhuo Gao, Bo Gao, Shenglong Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Cancer Inhibition and In Vivo Osteointegration and Compatibility of Gallium-Doped Bioactive Glasses for Osteosarcoma Applications
Lucas Pereira de Souza, Filipe V. Ferreira, João Henrique Lopes, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 40, pp. 45156-45166
Open Access | Times Cited: 23
Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
Shuang Qin, Yuting Wang, Chunhui Ma, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 15
A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children
Feng Jiang, Xiao-Lin Miao, Xiaotian Zhang, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 30
Data-Driven Mathematical Model of Osteosarcoma
Trang Le, Sumeyye Su, Arkadz Kirshtein, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2367-2367
Open Access | Times Cited: 29
Efficacy and safety of anlotinib in patients with unresectable or metastatic bone sarcoma: A retrospective multiple institution study
Zhi‐Yong Liu, Songtao Gao, Liangyu Zhu, et al.
Cancer Medicine (2021) Vol. 10, Iss. 21, pp. 7593-7600
Open Access | Times Cited: 29
Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells
Alessia Salzillo, Angela Ragone, Annamaria Spina, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8586-8586
Open Access | Times Cited: 27
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)
Tong Yu, Weibo Jiang, Yang Wang, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 4
Open Access | Times Cited: 4
Tumor-oriented and chemo-photothermal nanoplatform capable of sensitizing chemotherapy and ferroptosis against osteosarcoma metastasis
Hongzi Wu, Bowen Li, Jichun Shao, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 132019-132019
Closed Access | Times Cited: 4
Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma
Guodan Zeng, Xinyu Liu, H. Lv, et al.
Biology (2025) Vol. 14, Iss. 1, pp. 61-61
Open Access
The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy
Xinlan Hu, Yan Wu, Mengmeng Yao, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 3, pp. 329-345
Closed Access
End-to-End Deep Learning Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Patients Using Routine MRI
Ping Yin, Xinyu Zhang, Ying Liu, et al.
Deleted Journal (2025)
Closed Access
Page 1 - Next Page

Scroll to top